tradingkey.logo
tradingkey.logo
Search

Neuropace Inc

NPCE
Add to Watchlist
13.970USD
-0.240-1.69%
Close 09-24 16:00(ET)
476.24MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-1.69%

5 Days

-1.27%

1 Month

-0.14%

6 Months

+5.28%

Year to Date

-9.52%

1 Year

+36.69%

Key Figures

14.210Open
14.867High
11.41KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.03%Turnover Ratio
14.210Prev. Close
13.630Low
158.25KTurnover
LossP/E Static
40.11P/B
0.00%Div Yield TTM
-20.63%ROA
19.60052wk High
0.08Volume Ratio
-27.14MNet Profit
34.09MShares
-0.6451EPS TTM
1.91Beta
-111.38%ROE
9.22052wk Low
8.71%Amplitude
82.83%Gross Margin
476.24MMarket Cap
-1.93Reward/Risk
3.93%Risk Rate
More news coming soon, stay tuned...

Neuropace Inc's Score

0.04vs previous score
Forecast8.44
Financial Health6.43
Technical3.26
Valuation Dimensions9.05
Institutional Confidence10.00
Risk Assessment5.08

Media Coverage

Coverage Level

Very Low
Very High
Neutral

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
20.000Target Price
+40.75%Upside Space
Current Rating2026-092026-082026-072026-062026-052026-042026-032026-02
Strong Buy22222222
Buy76666666
Hold00000000
Sell00000000
Strong Sell00000000

Neuropace Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D

Technical Indicators

Strong sell

Summary

Strong sell

Moving Average

Strong sell

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.18/-0.21
Revenue / Forecast
22.83M/22.65M

Neuropace Inc Profile

SectorHealthcare Equipment & Supplies
Ticker SymbolNPCE
Number of employees184
CountryUnited States of America

Ownership

ShareholdersProportion
Accelmed Growth Partners Management Ltd13.00%
Polar Capital LLP8.44%
Soleus Capital Management, L.P.7.93%
Morgan Stanley & Co. LLC7.46%
Shareholder TypesProportion
Investment Advisor/Hedge Fund26.52%
Private Equity20.14%
Investment Advisor19.07%
Hedge Fund18.94%

FAQs

What is the current price of Neuropace Inc (NPCE)?

The current price of Neuropace Inc (NPCE) is 13.97.

What is the symbol of Neuropace Inc?

The ticker symbol of Neuropace Inc is NPCE.

What is the 52-week high of Neuropace Inc?

The 52-week high of Neuropace Inc is 19.60.

What is the 52-week low of Neuropace Inc?

The 52-week low of Neuropace Inc is 9.22.

What is the market capitalization of Neuropace Inc?

The market capitalization of Neuropace Inc is 476.24M.

Is Neuropace Inc (NPCE) currently rated as Buy, Hold, or Sell?

According to analysts, Neuropace Inc (NPCE) has an overall rating of Buy, with a price target of 20.00.

What is the Earnings Per Share (EPS TTM) of Neuropace Inc (NPCE)?

The Earnings Per Share (EPS TTM) of Neuropace Inc (NPCE) is -0.65.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.